Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: The phospholipase DDHD1 as a new target in colorectal cancer therapy

Fig. 2

Effects of DDHD1 silencing on ERK and Akt signaling pathways. a Levels of ERK 1/2, phospho-ERK 1/2 were determined in the cell lysate of SW480 transfected with scrambled or DDHD1 siRNA using the Bio-Plex Pro Cell Signaling Assay (left panel) and western blot (right panel). b Levels of Akt and phospho-Akt were determined by the Bio-Plex Multiple Cytokine Assay (upper panel) and by FACS analysis (lower panel) in the SW480 transfected with scrambled or DDHD1 siRNA (*p ≤ 0.05; **p ≤ 0.01)

Back to article page